A responsible and productive alliance between the medical profession and the pharmaceutical industry is unquestionably beneficial to medical progress. However, not all interactions between the two merit unconditional praise. This position paper addresses controversial issues related to the ethics of physician encounters with industry. The Ethics Committee of the American College of Physicians acknowledges that there may be no easy answers to many of the questions raised by these issues, but it has identified certain areas where specific guidance may be provided to supplement continued reliance on individual physician judgment.
In recent years there has been increasing awareness of ethically
Physicians and the Pharmaceutical Industry. Ann Intern Med. 1990;112:624–626. doi: https://doi.org/10.7326/0003-4819-112-8-624
Download citation file:
Published: Ann Intern Med. 1990;112(8):624-626.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Ethics.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use